Universal Antioxidant — BBB-Penetrant Chelator

DHLA: The Brain-Side Mercury Chelator

Most chelators stop at the blood-brain barrier. Mercury, once it gets into neurons, sits there. DHLA — the reduced form of alpha-lipoic acid — is one of the very few molecules small and amphipathic enough to cross both membranes, grab the mercury, and walk it back out.

10 min read•Updated May 2026

Quick Facts

Chemical Name

Dihydrolipoic acid (DHLA); reduced form of R-alpha-lipoic acid

Solubility

Both water- and fat-soluble (amphipathic)

Daily Dose

300 mg R-ALA/day (which reduces to DHLA in cells); strict Cutler dosing

Half-Life

~3 hours — short, demanding round-the-clock dosing in chelation

Actions

Mercury/arsenic chelation, glutathione recycling, glucose disposal, BBB transit

Best For

Mercury body burden, diabetic neuropathy, oxidative neurodegeneration

What It Is

Alpha-lipoic acid (ALA) is an 8-carbon disulfide cofactor for mitochondrial dehydrogenase complexes. In its oxidized form it is ALA; reduced (by lipoamide dehydrogenase or NAD(P)H quinone dehydrogenase) it becomes DHLA, with both sulfurs as free sulfhydryl groups. The free -SH groups are what chelate metals and recycle other antioxidants.

ALA exists as two stereoisomers: R-ALA (the natural, endogenous form) and S-ALA (the synthetic mirror). R-ALA is what your mitochondria make and what the dehydrogenase enzymes use. Most cheap bulk product is racemic R/S mix. Pure R-ALA is more bioactive at lower doses.

You cannot buy stable DHLA in a bottle — it auto-oxidizes back to ALA on the shelf within hours. Instead you buy R-ALA, take it, and let your cells reduce it to DHLA in real time. The exception is some specialty cosmetic and IV formulations.

R-ALA vs ALA vs Na-RALA

• Racemic ALA (R/S mix) — cheap. Half the molecules are the synthetic mirror with reduced activity.
• R-ALA — natural enantiomer only. 2-3x more bioavailable. Unstable in heat / humidity.
• Na-R-ALA (sodium R-lipoate, Bio-Enhanced) — sodium salt of R-ALA. Heat-stable, ~40% higher Cmax. The Cutler-protocol favorite.
• Avoid time-release or sublingual — Cutler protocol requires sharp pulses, not sustained release.

How It Works

DHLA does four things almost no other molecule does in combination: it is both water- and fat-soluble, it crosses the BBB, it directly chelates mercury and arsenic, and it regenerates every other antioxidant in the body.

Four Mechanisms

Soft-metal chelation in brain tissue

Two adjacent sulfhydryls grab mercury with high affinity. Unlike DMSA or DMPS, DHLA crosses into neurons and grabs intraneuronal mercury that other chelators cannot reach.

Antioxidant network recycling

Regenerates ascorbate from dehydroascorbate, vitamin E from tocopheryl radical, ubiquinol from ubiquinone, glutathione from glutathione disulfide. The redox network hub.

GLUT4 translocation / glucose disposal

Promotes insulin-independent glucose uptake into muscle. The basis for the German diabetic neuropathy approval (Thioctacid 600 IV).

Mitochondrial dehydrogenase cofactor

Required by pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase. Underwrites the citric acid cycle and amino acid oxidation.

The diabetic neuropathy evidence is the strongest single application: SYDNEY and ALADIN trials showed 600 mg IV daily reduces neuropathic pain by ~50%. Oral 600 mg/day showed the same effect at slower onset (4 weeks). This is the indication where the European approval rests.

Kundalini & Awakening Support

Jana Dixon's Biology of Kundalini lists DHLA / R-ALA as a primary brain-detox tool for awakening cohorts with confirmed or suspected mercury burden — anyone with old amalgams, heavy fish consumption, or vaccine series in early life. The awakening process redistributes metals; without a BBB-penetrant chelator, redistribution can land mercury back in the limbic system.

The second relevance is the universal antioxidant network. The awakening state runs the redox budget at full output. DHLA's ability to regenerate vitamin C, vitamin E, glutathione, and CoQ10 means a single molecule keeps the entire defense network in play. Dixon recommends pairing DHLA with vitamin C, vitamin E, selenium, and high-dose B-complex.

Nervous System Roles

• Limbic mercury removal — the only chelator that pulls intraneuronal mercury at clinically meaningful rates.
• Mitochondrial biogenesis — activates AMPK and PGC-1-alpha. Builds new mitochondria.
• Glutamate-related neuropathy buffer — reduces oxidative stress in the dorsal root ganglion and spinal cord.
• Insulin sensitization — corrects the insulin resistance that often accompanies prolonged sympathetic activation.

Detox Benefits

The reason Andy Cutler built an entire chelation framework around ALA (and DMSA): no other oral chelator combines mercury affinity with brain access. The tradeoff is that DHLA also redistributes mercury aggressively if dosed incorrectly.

•Mercury chelation (brain) — Cutler protocol: ALA every 3 hours, day and night, in rounds of 3 consecutive days. Halflife dictates frequency.
•Arsenic chelation — same sulfhydryl affinity. Relevant for well water and rice-heavy diets.
•Glutathione system support — recycling means each glutathione molecule does more work. Conservative for cysteine pool.
•Acetaldehyde clearance — alcohol, candida, formaldehyde metabolites. Aldehyde dehydrogenase requires lipoate cofactor.
•Hepatic protection — German emergency-medicine protocol for amanita mushroom poisoning. Outperforms silymarin alone.

Dosing Protocol

General Antioxidant / Maintenance

• 200-300 mg R-ALA or 100 mg Na-R-ALA, twice daily with meals
• Pair with biotin 1 mg/day to prevent ALA-induced biotin depletion
• Not chelation dosing — does not require round-the-clock

Cutler Mercury Chelation Protocol

• 25-100 mg ALA every 3 hours, day and night, with alarms
• 3-day round, then minimum 4 days off
• Combine with DMSA every 4 hours during rounds (after amalgam removal only)
• Strict adherence — missed doses cause redistribution worse than not chelating
• Read Amalgam Illness before starting

Diabetic Neuropathy

• 600 mg ALA daily, 30 minutes before breakfast (insulin-sensitivity window)
• 4-12 week trial; pain reduction at 4 weeks, peripheral nerve conduction at 12
• Pair with benfotiamine 300 mg/day for AGE protection

Hepatic / Liver Support

• 300 mg twice daily with meals
• Stack with NAC, milk thistle, glycine for full Phase II support
• 3-month minimum; recheck LFTs

Contraindications & Cautions

⚠Active dental amalgams: Do NOT chelate with ALA while amalgams are still in your mouth. ALA mobilizes mercury that gets redistributed to brain. Amalgam removal by IAOMT-trained dentist first; wait 3 months before chelation.
⚠Off-schedule dosing in Cutler protocol: Halflife is short (~3 hours). Missing doses mid-round causes worse symptoms than not chelating. If you cannot commit to 3-hour intervals around the clock, do not start.
⚠Thiamine deficiency: ALA can precipitate Wernicke encephalopathy in malnourished or alcoholic patients. Pretreat with thiamine 100 mg.
⚠Hypoglycemia: ALA improves insulin sensitivity. Adjust diabetes medications under physician supervision.
⚠Biotin depletion: Competes with biotin at intestinal transporter. Supplement biotin 1-5 mg/day with chronic ALA use.
⚠Insulin autoimmune syndrome (Hirata disease): Rare, but documented after ALA in HLA-DR4 patients of Japanese / Korean ancestry. Watch for spontaneous hypoglycemia.
⚠Pregnancy: Insufficient safety data. Avoid.

Best Products

Doctor's Best — Stabilized R-Lipoic Acid (Na-RALA) 100 mg

Sodium-R-lipoate, the heat-stable Bio-Enhanced form. Sharp absorption pulse suitable for Cutler chelation rounds.

Check Price on Amazon →

Jarrow Formulas — R-Alpha Lipoic Acid 100 mg

Pure R-enantiomer, capsule. Reliable QC, third-party assayed. Convenient 100 mg unit for dose splitting.